Thomas B. Cooper

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

Deepak Cyril D’Souza, Edward Perry, Lisa Macdougall et al. · Neuropsychopharmacology · 2004 · 1K citations · Full text

Medicine, Pharmacology, Psychiatry +12

Increased baseline occupancy of D ₂ receptors by dopamine in schizophrenia

Anissa Abi‐Dargham, Janine Rodenhiser, David Printz et al. · Proceedings of the National Academy of Sciences · 2000 · 1K citations · Full text

Medicine, Neuroscience, Pharmacology +17

Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive Therapy

Harold A. Sackeïm, Roger F. Haskett, Benoit H. Mulsant et al. · JAMA · 2001 · 689 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

Deepak Cyril D’Souza, Walid Abi‐Saab, Steven Madonick et al. · Biological Psychiatry · 2005 · 612 citations

Medicine, Neuroscience, Pharmacology +12

Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

Lawrence S. Kegeles, Anissa Abi‐Dargham, W. Gordon Frankle et al. · Archives of General Psychiatry · 2010 · 565 citations

Medicine, Neuroscience, Psychiatry +17